Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

‘Unitary SPC’ Proves Popular With EU Stakeholders

Executive Summary

A consultation has found that most stakeholders support the idea of a unitary supplementary protection certificate to complement the future unitary patent system in the EU, and that a re-examination of the way the “Bolar” research exemption works would be worthwhile. Interestingly, the consultation revealed that while some innovator company respondents saw the SPC as the main factor in making investment decisions in the EU, most rated it only "moderately" important.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS123356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel